Company to share preclinical data across diverse pipeline of iNK, γδ iT, and αβ iT cell therapy programs for oncology and autoimmune disease (AID) – – Preclinical data on development of iPSC-derived ...

免疫检查点阻断（ICB）是近年来极为热门的一类癌症免疫治疗手段，但目前仅有30%左右的患者对该疗法有效，因此亟需开发能有效预测免疫治疗疗效的生物标志物，实现精准、高效的个体化治疗。近日，国际顶级期刊 Cell ...

We couldn't do what we do without our volunteers and donors. Together, we're making a difference – and you can, too. Become a volunteer, make a tax-deductible donation, or participate in a fundraising ...